These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 38072359

  • 1. Evaluation of tolerance to mercaptopurine in patients with inflammatory bowel disease and gastrointestinal intolerance to azathioprine.
    Bastida G, Alvarez-Sotomayor D, Aguas M, Iborra M, Del Hoyo J, Béjar-Serrano S, Garrido-Marín A, Valero-Pérez E, Nos P.
    Gastroenterol Hepatol; 2024 May; 47(5):473-480. PubMed ID: 38072359
    [Abstract] [Full Text] [Related]

  • 2. Clinical Value of Mercaptopurine After Failing Azathioprine Therapy in Patients With Inflammatory Bowel Disease.
    Meijer B, Seinen ML, Leijte NN, Mulder CJ, van Bodegraven AA, de Boer NK.
    Ther Drug Monit; 2016 Aug; 38(4):463-70. PubMed ID: 27158876
    [Abstract] [Full Text] [Related]

  • 3. A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta-analysis.
    Kennedy NA, Rhatigan E, Arnott ID, Noble CL, Shand AG, Satsangi J, Lees CW.
    Aliment Pharmacol Ther; 2013 Nov; 38(10):1255-66. PubMed ID: 24117596
    [Abstract] [Full Text] [Related]

  • 4. Safety of azathioprine and 6-mercaptopurine in patients with inflammatory bowel disease naïve to thiopurine treatment
.
    Alaish R, Lundgren D, Suhr OB, Werner M, Karling P.
    Int J Clin Pharmacol Ther; 2017 Jul; 55(7):594-600. PubMed ID: 28406092
    [Abstract] [Full Text] [Related]

  • 5. Tolerability profile of thiopurines in inflammatory bowel disease: a prospective experience.
    Macaluso FS, Renna S, Maida M, Dimarco M, Sapienza C, Affronti M, Orlando E, Rizzuto G, Orlando R, Ventimiglia M, Cottone M, Orlando A.
    Scand J Gastroenterol; 2017 Sep; 52(9):981-987. PubMed ID: 28554266
    [Abstract] [Full Text] [Related]

  • 6. Increased dosing requirements for 6-mercaptopurine and azathioprine in inflammatory bowel disease patients six years and younger.
    Grossman AB, Noble AJ, Mamula P, Baldassano RN.
    Inflamm Bowel Dis; 2008 Jun; 14(6):750-5. PubMed ID: 18266236
    [Abstract] [Full Text] [Related]

  • 7. Sperm DNA Integrity is Unaffected by Thiopurine Treatment in Men With Inflammatory Bowel Disease.
    Grosen A, Nersting J, Bungum M, Christensen LA, Schmiegelow K, Spanò M, Julsgaard M, Cordelli E, Leter G, Larsen PB, Hvas CL, Kelsen J.
    J Crohns Colitis; 2019 Jan 01; 13(1):3-11. PubMed ID: 29917107
    [Abstract] [Full Text] [Related]

  • 8. 6-Thioguanine seems promising in azathioprine- or 6-mercaptopurine-intolerant inflammatory bowel disease patients: a short-term safety assessment.
    Derijks LJ, de Jong DJ, Gilissen LP, Engels LG, Hooymans PM, Jansen JB, Mulder CJ.
    Eur J Gastroenterol Hepatol; 2003 Jan 01; 15(1):63-7. PubMed ID: 12544696
    [Abstract] [Full Text] [Related]

  • 9. Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine.
    Dubinsky MC, Feldman EJ, Abreu MT, Targan SR, Vasiliauskas EA.
    Am J Gastroenterol; 2003 May 01; 98(5):1058-63. PubMed ID: 12809828
    [Abstract] [Full Text] [Related]

  • 10. Normal response to vaccines in inflammatory bowel disease patients treated with thiopurines.
    Dotan I, Werner L, Vigodman S, Agarwal S, Pfeffer J, Horowitz N, Malter L, Abreu M, Ullman T, Guzner-Gur H, Halpern Z, Mayer L.
    Inflamm Bowel Dis; 2012 Feb 01; 18(2):261-8. PubMed ID: 21438101
    [Abstract] [Full Text] [Related]

  • 11. More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing.
    Broekman MMTJ, Coenen MJH, van Marrewijk CJ, Wanten GJA, Wong DR, Verbeek ALM, Klungel OH, Hooymans PM, Guchelaar HJ, Scheffer H, Derijks LJJ, de Jong DJ, TOPIC Recruitment Team.
    Inflamm Bowel Dis; 2017 Oct 01; 23(10):1873-1881. PubMed ID: 28644183
    [Abstract] [Full Text] [Related]

  • 12. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.
    Chande N, Patton PH, Tsoulis DJ, Thomas BS, MacDonald JK.
    Cochrane Database Syst Rev; 2015 Oct 30; 2015(10):CD000067. PubMed ID: 26517527
    [Abstract] [Full Text] [Related]

  • 13. Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease.
    Kirschner BS.
    Gastroenterology; 1998 Oct 30; 115(4):813-21. PubMed ID: 9753482
    [Abstract] [Full Text] [Related]

  • 14. Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine.
    Bonaz B, Boitard J, Marteau P, Lémann M, Coffin B, Flourié B, Belaiche J, Cadiot G, Metman EH, Cortot A, Colombel JF, Getaid.
    Aliment Pharmacol Ther; 2003 Aug 15; 18(4):401-8. PubMed ID: 12940925
    [Abstract] [Full Text] [Related]

  • 15. Xanthine oxidase activity in thiopurine curative Chinese inflammatory bowel disease patients.
    Ding L, Zhang FB, Liu H, Gao X, Bi HC, Huang L, Wang XD, Chen BL, Zhang Y, Lv C, Hu PJ, Huang M.
    Pharmacol Res Perspect; 2021 May 15; 9(3):e00764. PubMed ID: 33929082
    [Abstract] [Full Text] [Related]

  • 16. 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease.
    Dubinsky MC, Yang H, Hassard PV, Seidman EG, Kam LY, Abreu MT, Targan SR, Vasiliauskas EA.
    Gastroenterology; 2002 Apr 15; 122(4):904-15. PubMed ID: 11910342
    [Abstract] [Full Text] [Related]

  • 17. Azathioprine and mercaptopurine in the management of patients with chronic, active microscopic colitis.
    Münch A, Fernandez-Banares F, Munck LK.
    Aliment Pharmacol Ther; 2013 Apr 15; 37(8):795-8. PubMed ID: 23432370
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine.
    Wahed M, Louis-Auguste JR, Baxter LM, Limdi JK, McCartney SA, Lindsay JO, Bloom SL.
    Aliment Pharmacol Ther; 2009 Sep 15; 30(6):614-20. PubMed ID: 19552632
    [Abstract] [Full Text] [Related]

  • 19. Leukopenia predicts remission in patients with inflammatory bowel disease and Behcet's disease on thiopurine maintenance.
    Park MS, Kim DH, Kim DH, Park SJ, Hong SP, Kim TI, Kim WH, Cheon JH.
    Dig Dis Sci; 2015 Jan 15; 60(1):195-204. PubMed ID: 25239495
    [Abstract] [Full Text] [Related]

  • 20. Discordant erythrocyte sedimentation rate and C-reactive protein in children with inflammatory bowel disease taking azathioprine or 6-mercaptopurine.
    Barnes BH, Borowitz SM, Saulsbury FT, Hellems M, Sutphen JL.
    J Pediatr Gastroenterol Nutr; 2004 May 15; 38(5):509-12. PubMed ID: 15097439
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.